Metraipolis › archive › dc_0e69c2d87fea

National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada — Europe PMC PMID:41600942

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41600942
DOI
10.3390/vaccines14010026
License (as archived)
solo-consultazione
Archived
2026-11-07T10:35:04.527Z
SHA-256 of the archived text
060403034ec5277c21bde0c01f9d3dc335b91817e9068285e54811996609652a
Stable URL of this page
https://metraipolis.com/documento/dc_0e69c2d87fea

How to cite

National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada — Europe PMC PMID:41600942 — Europe PMC (en), https://europepmc.org/article/MED/41600942 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e69c2d87fea (Metraipolis archive dc_0e69c2d87fea, sha256 060403034ec5277c21bde0c01f9d3dc335b91817e9068285e54811996609652a)
BibTeX
@misc{dc0e69c2d87fea,
  title = {National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada — Europe PMC PMID:41600942},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41600942},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e69c2d87fea; sha256 060403034ec5277c21bde0c01f9d3dc335b91817e9068285e54811996609652a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41600942. Agents can read the archived copy with the MCP tool read_document.